Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a comprehensive Locations section listing participating sites across multiple states and Quebec and updated the page revision to v3.3.3.SummaryDifference1%

- Check51 days agoChange DetectedThe page shows a version update from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check58 days agoChange DetectedThe Publications section wording was updated to indicate that PubMed publications are automatically filled and may not all be about the study, and the revision label was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe banner about government funding and operating status was removed from the page.SummaryDifference0.3%

- Check79 days agoChange DetectedMinor layout and formatting tweaks observed on the page; core study details, locations, eligibility criteria, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.